Home » Misc » What is the etiology of osteoporosis
What is the etiology of osteoporosis
Osteoporosis - Symptoms and causesOverviewOsteoporosis causes bones to become weak and brittle — so brittle that a fall or even mild stresses such as bending over or coughing can cause a fracture. Osteoporosis-related fractures most commonly occur in the hip, wrist or spine. Bone is living tissue that is constantly being broken down and replaced. Osteoporosis occurs when the creation of new bone doesn't keep up with the loss of old bone. Osteoporosis affects men and women of all races. But white and Asian women, especially older women who are past menopause, are at highest risk. Medications, healthy diet and weight-bearing exercise can help prevent bone loss or strengthen already weak bones. Products & Services- Available Health Products from Mayo Clinic Store
- Book: Mayo Clinic on Osteoporosis
- Book: Mayo Clinic The Menopause Solution
- Book: Taking Care of You
SymptomsThere typically are no symptoms in the early stages of bone loss. But once your bones have been weakened by osteoporosis, you might have signs and symptoms that include: - Back pain, caused by a fractured or collapsed vertebra
- Loss of height over time
- A stooped posture
- A bone that breaks much more easily than expected
When to see a doctorYou might want to talk to your doctor about osteoporosis if you went through early menopause or took corticosteroids for several months at a time, or if either of your parents had hip fractures. Request an Appointment at Mayo Clinic From Mayo Clinic to your inbox
Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health. To provide you with the most relevant and helpful information, and understand which
information is beneficial, we may combine your email and website usage information with
other information we have about you. If you are a Mayo Clinic patient, this could
include protected health information. If we combine this information with your protected
health information, we will treat all of that information as protected health
information and will only use or disclose that information as set forth in our notice of
privacy practices. You may opt-out of email communications at any time by clicking on
the unsubscribe link in the e-mail.
CausesOsteoporosis weakens boneOsteoporosis weakens boneUnder a microscope, healthy bone has the appearance of a honeycomb matrix (top). Osteoporotic bone (bottom) is more porous. Your bones are in a constant state of renewal — new bone is made and old bone is broken down. When you're young, your body makes new bone faster than it breaks down old bone and your bone mass increases. After the early 20s this process slows, and most people reach their peak bone mass by age 30. As people age, bone mass is lost faster than it's created. How likely you are to develop osteoporosis depends partly on how much bone mass you attained in your youth. Peak bone mass is partly inherited and varies also by ethnic group. The higher your peak bone mass, the more bone you have "in the bank" and the less likely you are to develop osteoporosis as you age. Risk factorsA number of factors can increase the likelihood that you'll develop osteoporosis — including your age, race, lifestyle choices, and medical conditions and treatments. Unchangeable risksSome risk factors for osteoporosis are out of your control, including: - Your sex. Women are much more likely to develop osteoporosis than are men.
- Age. The older you get, the greater your risk of osteoporosis.
- Race. You're at greatest risk of osteoporosis if you're white or of Asian descent.
- Family history. Having a parent or sibling with osteoporosis puts you at greater risk, especially if your mother or father fractured a hip.
- Body frame size. Men and women who have small body frames tend to have a higher risk because they might have less bone mass to draw from as they age.
Hormone levelsOsteoporosis is more common in people who have too much or too little of certain hormones in their bodies. Examples include: - Sex hormones. Lowered sex hormone levels tend to weaken bone. The fall in estrogen levels in women at menopause is one of the strongest risk factors for developing osteoporosis. Treatments for prostate cancer that reduce testosterone levels in men and treatments for breast cancer that reduce estrogen levels in women are likely to accelerate bone loss.
- Thyroid problems. Too much thyroid hormone can cause bone loss. This can occur if your thyroid is overactive or if you take too much thyroid hormone medication to treat an underactive thyroid.
- Other glands. Osteoporosis has also been associated with overactive parathyroid and adrenal glands.
Dietary factorsOsteoporosis is more likely to occur in people who have: - Low calcium intake. A lifelong lack of calcium plays a role in the development of osteoporosis. Low calcium intake contributes to diminished bone density, early bone loss and an increased risk of fractures.
- Eating disorders. Severely restricting food intake and being underweight weakens bone in both men and women.
- Gastrointestinal surgery. Surgery to reduce the size of your stomach or to remove part of the intestine limits the amount of surface area available to absorb nutrients, including calcium. These surgeries include those to help you lose weight and for other gastrointestinal disorders.
Steroids and other medicationsLong-term use of oral or injected corticosteroid medications, such as prednisone and cortisone, interferes with the bone-rebuilding process. Osteoporosis has also been associated with medications used to combat or prevent: - Seizures
- Gastric reflux
- Cancer
- Transplant rejection
Medical conditionsThe risk of osteoporosis is higher in people who have certain medical problems, including: - Celiac disease
- Inflammatory bowel disease
- Kidney or liver disease
- Cancer
- Multiple myeloma
- Rheumatoid arthritis
Lifestyle choicesSome bad habits can increase your risk of osteoporosis. Examples include: - Sedentary lifestyle. People who spend a lot of time sitting have a higher risk of osteoporosis than do those who are more active. Any weight-bearing exercise and activities that promote balance and good posture are beneficial for your bones, but walking, running, jumping, dancing and weightlifting seem particularly helpful.
- Excessive alcohol consumption.
Regular consumption of more than two alcoholic drinks a day increases the risk of osteoporosis. - Tobacco use. The exact role tobacco plays in osteoporosis isn't clear, but it has been shown that tobacco use contributes to weak bones.
ComplicationsCompression fracturesCompression fracturesThe bones that make up your spine (vertebrae) can weaken to the point that they crumple and collapse, which may result in back pain, lost height and a hunched posture. Bone fractures, particularly in the spine or hip, are the most serious complications of osteoporosis. Hip fractures often are caused by a fall and can result in disability and even an increased risk of death within the first year after the injury. In some cases, spinal fractures can occur even if you haven't fallen. The bones that make up your spine (vertebrae) can weaken to the point of collapsing, which can result in back pain, lost height and a hunched forward posture. PreventionGood nutrition and regular exercise are essential for keeping your bones healthy throughout your life. CalciumMen and women between the ages of 18 and 50 need 1,000 milligrams of calcium a day. This daily amount increases to 1,200 milligrams when women turn 50 and men turn 70. Good sources of calcium include: - Low-fat dairy products
- Dark green leafy vegetables
- Canned salmon or sardines with bones
- Soy products, such as tofu
- Calcium-fortified cereals and orange juice
If you find it difficult to get enough calcium from your diet, consider taking calcium supplements. However, too much calcium has been linked to kidney stones. Although yet unclear, some experts suggest that too much calcium, especially in supplements, can increase the risk of heart disease. The Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine recommends that total calcium intake, from supplements and diet combined, should be no more than 2,000 milligrams daily for people older than 50. Vitamin DVitamin D improves the body's ability to absorb calcium and improves bone health in other ways. People can get some of their vitamin D from sunlight, but this might not be a good source if you live in a high latitude, if you're housebound, or if you regularly use sunscreen or avoid the sun because of the risk of skin cancer. Dietary sources of vitamin D include cod liver oil, trout and salmon. Many types of milk and cereal have been fortified with vitamin D. Most people need at least 600 international units (IU) of vitamin D a day. That recommendation increases to 800 IU a day after age 70. People without other sources of vitamin D and especially with limited sun exposure might need a supplement. Most multivitamin products contain between 600 and 800 IU of vitamin D. Up to 4,000 IU of vitamin D a day is safe for most people. ExerciseExercise can help you build strong bones and slow bone loss. Exercise will benefit your bones no matter when you start, but you'll gain the most benefits if you start exercising regularly when you're young and continue to exercise throughout your life. Combine strength training exercises with weight-bearing and balance exercises. Strength training helps strengthen muscles and bones in your arms and upper spine. Weight-bearing exercises — such as walking, jogging, running, stair climbing, skipping rope, skiing and impact-producing sports — affect mainly the bones in your legs, hips and lower spine. Balance exercises such as tai chi can reduce your risk of falling especially as you get older. More Information- Exercising with osteoporosis
By Mayo Clinic Staff RelatedAssociated ProceduresNews from Mayo ClinicProducts & ServicesOsteoporosis - Diagnosis and treatmentDiagnosisYour bone density can be measured by a machine that uses low levels of X-rays to determine the proportion of mineral in your bones. During this painless test, you lie on a padded table as a scanner passes over your body. In most cases, only certain bones are checked — usually in the hip and spine. More Information- Bone density test
- CT scan
- Ultrasound
TreatmentTreatment recommendations are often based on an estimate of your risk of breaking a bone in the next 10 years using information such as the bone density test. If your risk isn't high, treatment might not include medication and might focus instead on modifying risk factors for bone loss and falls. BisphosphonatesFor both men and women at increased risk of fracture, the most widely prescribed osteoporosis medications are bisphosphonates. Examples include: - Alendronate (Binosto, Fosamax)
- Ibandronate (Boniva)
- Risedronate (Actonel, Atelvia)
- Zoledronic acid (Reclast, Zometa)
Side effects include nausea, abdominal pain and heartburn-like symptoms. These are less likely to occur if the medicine is taken properly. Intravenous forms of bisphosphonates don't cause stomach upset but can cause fever, headache and muscle aches. A very rare complication of bisphosphonates is a break or crack in the middle of the thighbone. A second rare complication is delayed healing of the jawbone (osteonecrosis of the jaw). This can occur after an invasive dental procedure, such as removing a tooth. DenosumabCompared with bisphosphonates, denosumab (Prolia, Xgeva) produces similar or better bone density results and reduces the chance of all types of fractures. Denosumab is delivered via a shot under the skin every six months. Similar to bisphosphonates, denosumab has the same rare complication of causing breaks or cracks in the middle of the thighbone and osteonecrosis of the jaw. If you take denosumab, you might need to continue to do so indefinitely. Recent research indicates there could be a high risk of spinal column fractures after stopping the drug. Hormone-related therapyEstrogen, especially when started soon after menopause, can help maintain bone density. However, estrogen therapy can increase the risk of breast cancer and blood clots, which can cause strokes. Therefore, estrogen is typically used for bone health in younger women or in women whose menopausal symptoms also require treatment. Raloxifene (Evista) mimics estrogen's beneficial effects on bone density in postmenopausal women, without some of the risks associated with estrogen. Taking this drug can reduce the risk of some types of breast cancer. Hot flashes are a possible side effect. Raloxifene also may increase your risk of blood clots. In men, osteoporosis might be linked with a gradual age-related decline in testosterone levels. Testosterone replacement therapy can help improve symptoms of low testosterone, but osteoporosis medications have been better studied in men to treat osteoporosis and thus are recommended alone or in addition to testosterone. Bone-building medicationsIf you have severe osteoporosis or if the more common treatments for osteoporosis don't work well enough, your doctor might suggest trying: - Teriparatide (Bonsity, Forteo). This powerful drug is similar to parathyroid hormone and stimulates new bone growth. It's given by daily injection under the skin for up to two years.
- Abaloparatide (Tymlos) is another drug similar to parathyroid hormone. This drug can be taken for only two years.
- Romosozumab (Evenity). This is the newest bone-building medication to treat osteoporosis. It is given as an injection every month at your doctor's office and is limited to one year of treatment.
After you stop taking any of these bone-building medications, you generally will need to take another osteoporosis drug to maintain the new bone growth. More Information- Osteoporosis treatment: Medications can help
- Osteoporosis: How long must I take bisphosphonates?
- Risks of osteoporosis drugs
Request an Appointment at Mayo Clinic From Mayo Clinic to your inbox
Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health. To provide you with the most relevant and helpful information, and understand which
information is beneficial, we may combine your email and website usage information with
other information we have about you. If you are a Mayo Clinic patient, this could
include protected health information. If we combine this information with your protected
health information, we will treat all of that information as protected health
information and will only use or disclose that information as set forth in our notice of
privacy practices. You may opt-out of email communications at any time by clicking on
the unsubscribe link in the e-mail.
Clinical trials
Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.
Lifestyle and home remediesThese suggestions might help reduce your risk of developing osteoporosis or breaking bones: - Don't smoke. Smoking increases rates of bone loss and the chance of fracture.
- Limit alcohol. Consuming more than two alcoholic drinks a day may decrease bone formation. Being under the influence of alcohol also can increase your risk of falling.
- Prevent falls. Wear low-heeled shoes with nonslip soles and check your house for electrical cords, area rugs and slippery surfaces that might cause you to fall. Keep rooms brightly lit, install grab bars just inside and outside your shower door, and make sure you can get into and out of your bed easily.
Preparing for your appointmentYour doctor might suggest bone density testing. Screening for osteoporosis is recommended for all women over age 65. Some guidelines also recommend screening men by age 70, especially if they have health issues likely to cause osteoporosis. If you have a broken bone after a minor force injury, such as a simple fall, bone density testing may be important to assess your risk of more fractures. If the test results show very low bone density or you have other complex health issues, you might be referred to a doctor who specializes in metabolic disorders (endocrinologist) or a doctor who specializes in diseases of the joints, muscles or bones (rheumatologist). Here's some information to help you get ready for your appointment. What you can do- Write down symptoms you've noticed, though it's possible you may not have any.
- Write down key personal information, including major stresses or recent life changes.
- Make a list of all medications, vitamins and supplements that you take or have taken, including doses. It's especially helpful if you record the type and dose of calcium and vitamin D supplements, because many different preparations are available.
If you're not sure what information your doctor might need, take the bottles with you or take a picture of the label with your smartphone and share it with your doctor. - Write down questions to ask your doctor.
For osteoporosis, basic questions to ask your doctor include: - Do I need to be screened for osteoporosis?
- What treatments are available, and which do you recommend?
- What side effects might I expect from treatment?
- Are there alternatives to the treatment you're suggesting?
- I have other health conditions. How can I best manage them together?
- Do I need to restrict my activities?
- Do I need to change my diet?
- Do I need to take supplements?
- Is there a physical therapy program that would benefit me?
- What can I do to prevent falls?
Don't hesitate to ask other questions. What to expect from your doctorYour doctor is likely to ask you questions, such as: - Have you broken bones?
- Have you gotten shorter?
- How is your diet, especially your dairy intake? Do you think you get enough calcium? Vitamin D?
- How often do you exercise? What type of exercise do you do?
- How is your balance? Have you fallen?
- Do you have a family history of osteoporosis?
- Has a parent broken a hip?
- Have you ever had stomach or intestinal surgery?
- Have you taken corticosteroid medications (prednisone, cortisone) as pills, injections or creams?
By Mayo Clinic Staff RelatedAssociated ProceduresNews from Mayo ClinicProducts & Services Osteoporosis | Clinical Rheumatology Hospital №25 Osteoporosis | Clinical Rheumatology Hospital №25 What is osteoporosis? Osteoporosis is a systemic disease affecting all bones of the skeleton. Osteoporosis of the bones is accompanied by a decrease in bone density and strength, which leads to a high risk of fractures even with minimal trauma, such as a fall from one's height or lifting a load of about 10 kilograms. Most common fractures of joints and bones in osteoporosis: - fracture of the radius in the “typical location”
- hip fractures (50% of patients remain disabled)
- compression fractures of the spine
The following main forms of osteoporosis are distinguished: Primary osteoporosis: - Type I (postmenopausal) develops during menopause in women;
- Type II (senile) occurs with the same frequency in women and in men of elderly and senile age (70 years and older)
Secondary osteoporosis is a complication of many diseases - endocrine, inflammatory (especially rheumatic), hematological, gastroenterological, etc. or drug therapy and can develop at any age, both in women and men. What causes osteoporosis? Factors contributing to the development of osteoporosis: - Women suffer much more often than men. So, during the first five years after the onset of menopause, women lose ¼ of their bone mass. Early (before age 45) and surgical menopause (after removal of the ovaries) increase the risk of osteoporosis.
- Disorders that limit movement may contribute to the development of osteoporosis. Therefore, low physical activity can contribute to the development of osteoporosis.
- Chronic diseases of the gastrointestinal tract, accompanied by a decrease in the absorption of nutrients, vitamins, macro- and microelements, disrupt bone metabolism.
- Kidney diseases leading to chronic renal failure
- Endocrine diseases, long-term use of glucocorticoid hormones and thyroid hormones (L-thyroxine) is an additional risk factor
- Bad habits (smoking, alcohol abuse, coffee)
- Hereditary predisposition
How to suspect osteoporosis? Symptoms of osteoporosis. Signs of osteoporosis. The disease is often detected in the later stages, when there is already a marked decrease in bone density. Osteoporosis does not cause any pain until a fracture develops. No wonder the disease is called the "silent epidemic". That is why it is important to pay attention to such signs of the development of the disease as a decrease in height by several centimeters, a change in posture (the formation of a thoracic humpback kyphosis) Diagnosis of osteoporosis. The only method to confirm the diagnosis and detect the disease in the early stages is bone densitometry (measurement of bone density, determination of bone density). This study can be done either in the direction of the clinic, or on a paid basis. Indications for densitometry see here... The main directions of osteoporosis prevention: - Physical activity - gymnastics, isometric exercises, swimming.
- Proper nutrition - a meal high in protein, calcium and vitamin D (dairy products) and relatively low in phosphate, salt and fiber.
- Elimination of risk factors for osteoporosis - smoking, excessive intake of alcohol, caffeine (less than 4 cups per day), heavy physical exertion.
- Elimination of risk factors for accidental loss of balance - correction of visual impairment, if possible, the exclusion of the use of hypnotics and sedative drugs.
How to treat osteoporosis? Treatment of osteoporosis is aimed at reducing the risk of osteoporotic fractures. Bisphosphonates (in particular, alendronic acid), salmon calcitonin (miacalcic), calcium and vitamin D, hormone replacement therapy, active vitamin D metabolites are indicated as therapy. a specialist either in the direction of the clinic, or on a paid basis. RHEUMATOLOGIST'S CONSULTATION Find: Accessible environment Single portal Attention! Rules for receiving transfers for patients (strictly specified hours): Monday-Friday : from 16:00 to 19:00; Saturday-Sunday : from 10:00 to 12:00 and from 16:00 to 19:00 Transfers are accepted in a plastic bag. The package with the transfer must indicate the name of the patient to whom it is intended, department, room number, date. SanPiN 2.1.3.2630-10 "Sanitary and epidemiological requirements for organizations engaged in medical activities." SanPiN 2.3.2.1324-03 "Hygienic requirements for shelf life and storage conditions of food products") Administration of St. Petersburg GBUZ "KRB No. 25" Paid Services Department Phone 670-30-80 Mon-Fri from 09:00 to 17:00 Time of blood sampling in the department of paid services Mon-Thu from 09:30 to 14:00 Friday from 09:30 to 13:00. It is possible to carry out examination in one visit . You must pre-register by calling the paid services department Announcement! Specialists Departments Our services We treat A timely visit to a rheumatologist contributes to a more rapid decrease in the activity of the disease, reduces the likelihood of complications and increases the possibility of maintaining working capacity. You asked… Visually impaired version Hospital Information about the personal data of the authors of applications sent electronically is stored and processed in compliance with the requirements of the Russian legislation on personal data. Read more... The Administration of the Governor of St. Petersburg is conducting a comprehensive survey of the business community in order to assess the conditions for doing business in St. Petersburg and determine areas for improving the work of the executive authorities. Read more… Diagnostics Services In the Clinical Rheumatology Hospital No. 25 you can get medical care on a paid basis Read more... Osteoporosis: clinic, diagnosis, treatment | Marova E.I. O Steoporosis is the most common metabolic disease of the skeletal system, characterized by a decrease in the mass of bone tissue per unit volume, leading to bone fragility and fractures. Postmenopausal osteoporosis belongs to the class of primary osteoporosis. It is known that a decrease in the secretion of sex hormones during menopause has a direct and indirect effect on the state of bone metabolism. A decrease in the content of estrogen leads to a violation of calcium metabolism, which is accompanied by a decrease in bone mineral density (BMD). In addition, there is a suppression of osteoblast activity, which leads to the predominance of resorption over the processes of bone tissue formation. Postmenopausal osteoporosis accounts for 85% of the total number of primary osteoporosis. Senile osteoporosis - the so-called second type of osteoporosis, in the pathogenesis of which an important role is played by a decrease in calcium absorption in the intestine, which is also facilitated by vitamin D deficiency caused by a decrease in its intake with food, slowing down its formation in the skin from provitamin D. The greatest importance in the pathogenesis of senile osteoporosis has a deficiency of active metabolites of vitamin D due to a decrease in its synthesis in the kidneys. In senile osteoporosis, the development of resistance to vitamin D plays a certain role - i.e. deficiency of receptors 1,25(OH) 2 D. These factors cause the development of transient hypocalcemia, which leads to increased production of parathyroid hormone. As a result of secondary hyperparathyroidism, bone resorption increases, while bone formation is reduced in old age. Steroid osteoporosis also belongs to the class of secondary osteoporosis and is caused by a pathological increase in endogenous production of glucocorticoids by the adrenal glands or occurs with the introduction of synthetic analogues of corticosteroids used to treat rheumatological, allergic, hematological, eye diseases, diseases of the skin, gastrointestinal tract ( gastrointestinal tract), kidneys, liver. Steroid osteoporosis occurs in diseases characterized by increased secretion of corticosteroids by the adrenal glands. These include Itsenko-Cushing's disease, in which adrenocorticotropic hormone (ACTH)-producing pituitary tumor leads to stimulation and hyperplasia of the adrenal cortex. In turn, tumors of the adrenal cortex, both benign and malignant, producing an increased amount of corticosteroids, are accompanied by the clinical picture of Cushing's syndrome. The decrease in bone mass occurs unevenly in different parts of the skeleton, in most cases it proceeds more actively in trabecular bones than in cortical ones. The pathogenesis of osteoporosis is shown in Figure 1. 1. Pathogenesis of osteoporosis Clinical manifestations . Magic, swords, axes, arrows, dragons, sorcerers, knights and much more awaits us in the long-awaited RPG Dragon Age: Inquisition. Its story originates from the previous part of the Dragon Age 2 toy. The events in it will take place in a fascinating world, and its name is Thedasu. The process of development of osteoporosis is characterized by a slow increase in bone loss and deformation of the vertebrae and can be asymptomatic for a long time. Acute intense pain in the affected spine is associated with compression of the bodies of one or more vertebrae, sharply limits the range of motion and causes excruciating suffering, sometimes leading patients to a severe depressive state. Osteoporosis is characterized by rib fractures occurring with pain in the chest. Pain syndrome in osteoporosis is explained by small bone microfractures and irritation of the periosteum. With the development of aseptic necrosis of the femoral heads, characteristic of osteoporosis, in patients gait is disturbed , which is called “duck gait”. . The process of development of osteoporosis is characterized by a slow increase in bone loss and deformation of the vertebrae and can be asymptomatic for a long time. in the affected spine is associated with compression of the bodies of one or more vertebrae, sharply limits the range of motion and causes excruciating suffering, sometimes leading patients to a severe depressive state. Osteoporosis is characterized by pain in the chest. in osteoporosis, they are explained by small bone microfractures and irritation of the periosteum. With the development of aseptic necrosis of the femoral heads, characteristic of osteoporosis, in patients, which is called "duck". Characteristic of osteoporosis is also a decrease in the height of adult patients by 2-3 cm , and with a long course of the disease up to 10-15 cm. In this case, the thoracic kyphosis increases and the pelvis tilts forward. Diagnosis The most common method for diagnosing osteopenic syndrome is visual assessment of radiographs of various parts of the skeleton . According to radiological signs, professor-radiologist A.I. Buchman distinguishes small, moderate and pronounced osteoporosis. Minor osteoporosis is characterized by a decrease in bone density, when there is an increase in the transparency of the radiographic shadow and coarse striation of the vertical trabeculae of the vertebrae. With moderate osteoporosis there is a pronounced decrease in bone density, characterized by biconcave vertebral body areas and wedge-shaped deformity of one vertebra. In severe osteoporosis there is a sharp increase in transparency, the so-called glass vertebrae and wedge-shaped deformity of several vertebrae. Using X-ray data osteoporosis can be diagnosed when up to 20-30% of bone mass has been lost . To a large extent, the diagnosis under these conditions depends on the qualifications of the radiologist. Currently, various methods of quantitative bone densitometry are used for early diagnosis of osteoporosis, which makes it possible to detect already 2-5% loss of bone mass, to assess the dynamics of the disease or the effectiveness of treatment. The most adequate method for osteoporosis is the use of dual-energy x-ray absorptiometry (DEXA), which allows measuring the content of bone mineral in any part of the skeleton, as well as determining the content of calcium salts, fat and muscle mass throughout the body. Axial computed tomography measures the BMD of the lumbar vertebrae, separating trabecular and cortical bone structures, measuring volumetric values in g/cm3. The standard (automatic) programs for DEXA densitometers are programs for the lumbar vertebrae, proximal femur, forearm bones, and the “whole body” program. Along with the absolute indicators of bone density in g/cm3 of the studied area, the Z-criterion is automatically calculated in the results of densitometry as a percentage of the sex and age population norm and in the values of the standard deviation from it (SD). The T-score is also calculated as a percentage or SD values of the peak bone mass of the persons of the corresponding sex. According to WHO recommendations, the severity of osteopenia or osteoporosis is assessed using the T-criterion (Table 1). Biochemical markers of bone metabolism They are examined to assess the rate of bone remodeling and diagnose osteoporosis with a high or low rate of bone metabolism, disunity or imbalance of its components: bone resorption and bone formation. The most accurate marker of bone formation is currently recognized as a study of the content of osteocalcin in the blood. They are studied to assess the rate of bone remodeling processes and the diagnosis of osteoporosis with a high or low rate of bone metabolism, dissociation or imbalance of its components: bone resorption and bone formation. The most accurate marker of bone formation is currently recognized as a study of the content of osteocalcin in the blood. Markers of bone resorption include urinary hydroxyproline excretion, acid tartrate-resistant phosphatase activity, and fasting urinary pyridinoline, deoxypyridinoline, and N-terminal telopeptide. The most informative marker of bone resorption is deoxypyridinoline. More than 150 patients with Itsenko-Cushing's disease were under our supervision, 40 of them after bilateral adrenalectomy, including 16 with Nelson's syndrome. More than 100 patients were observed in dynamics, both in the active stage of the disease and against the background of remission of hypercortisolism. Analysis of clinical and radiological data showed that in the active stage of the disease, pain in the spine was observed in 73% of patients, and its severity depended on the severity of the disease and was not related to the sex and age of the patients. According to the visual assessment of radiographs of the thoracic spine, radiological signs of osteoporosis were detected in 90% of patients, in the lumbar region - in 45%, rib fractures - in 52%, compression fractures of the vertebral bodies - in 40% of patients. Fractures of the peripheral bones of the skeleton were observed much less frequently, which confirms the predominant lesion of bones with a trabecular structure. Measurement of BMD performed in patients with Itsenko-Cushing's disease in 1991-1992. using dual-energy X-ray absorptiometry in the distal radius (areas of interest identified by the researchers) and in the lumbar vertebrae (areas of interest identified automatically), revealed the following. In patients with Itsenko-Cushing's disease, a decrease in BMD in the lumbar vertebrae, on average, to 72. 4 ± 5% of the age norm (according to the Z-criterion), was revealed, and BMD in the bones of the forearm remained practically unchanged. In patients with Nelson's syndrome, there was a similar decrease in BMD in the lumbar vertebrae - 70.6±6.3% of the age norm and a significant decrease in BMD in the distal radius up to 86.1%. The revealed decrease in BMD in patients with Nelson's syndrome can be explained by the more severe course of hypercortisolism in these patients before bilateral adrenalectomy, the presence of subsequent glucocorticoid replacement therapy, and the older age of these patients. Since 1996, we have been studying BMD using two methods: dual-energy X-ray absorptiometry using an Expert device from Lunar (Fig. 2) and ultrasonic densitometry (USD). The first method was used to measure BMD in the lumbar vertebrae and the proximal femur (femoral neck), the second method was used to determine the integral Stiffness index by measuring the ultrasound transmission speed and the attenuation coefficient of the ultrasonic wave in the calcaneus. In patients with Itsenko-Cushing's disease, BMD in the lumbar vertebrae was 81.7±4.2% of the age norm, which is consistent with the data of other researchers who found a decrease in BMD by 20%. In the femoral neck, this figure was 88.8% ± 3.9%, and Stiffness of the calcaneus was almost within the normal range (94.5±3.8%). It should be noted that pronounced changes in BMD were not observed in all patients with endogenous hypercortisolism. In Itsenko-Cushing's disease in the lumbar vertebrae, osteopenia was found in 32% of cases, osteoporosis - in 45%; normal BMD values - in 23%; with Nelson's syndrome, respectively, 36, 47 and 17% of cases. Changes in the femoral neck were detected much less frequently: in Itsenko-Cushing's disease, osteopenia was detected in 26% of cases, osteoporosis - in 22%, no changes - in 52%; with Nelson's syndrome - respectively 32, 38 and 30% of cases. Thus, our studies confirm the predominant lesion of bones with a trabecular structure in hypercortisolism, especially the vertebral bodies and ribs. Fig. 2. Apparatus "Expert XL", firm "Lunar" The most adequate method for early diagnosis of osteopenia in osteoporosis is osteodensitometry of the spine and radiography of the bones of the skull and thoracic vertebrae in the lateral projection. Treatment of osteoporosis Currently, there is a wide range of drugs for the treatment of osteoporosis, to a greater or lesser extent satisfying the criteria for the effectiveness of therapy (Table 2). For the treatment and prevention of osteoporosis, depending on its severity and severity, bisphosphonates, calcitonin, fluorides, active vitamin D metabolites. View table 2 With endogenous hypercortisolism (Itsenko-Cushing's disease or syndrome), a pronounced degree of osteoporosis with compression fractures of the vertebral bodies and rib fractures is often observed. In the active phase of the disease, vigorous treatment of osteoporosis is required; with severe pain syndrome, the drug of choice is calcitonin , used simultaneously with calcium salts and vitamin D preparations. In postmenopausal osteoporosis, it is also recommended to prescribe calcitonin at a dose of 100 IU (parenteral), and when the effect is achieved, 50-100 IU parenterally or 100-200 IU every other day in the form of an intranasal aerosol. In the treatment of secondary osteoporosis (in particular, steroid), antiresorptive agents and vitamin D preparations are most widely used. The Department of Neuroendocrinology of the Endocrinology Center of the Russian Academy of Medical Sciences has extensive experience in the treatment of patients with osteoporosis with bisphosphonates, fluorides, vitamin D preparations and calcium salts. The use of sodium fluoride led to an increase in BMD in the lumbar spine by 4.9% after 6 months in the first case, and 4-10% after 9 months in the second. |